Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 80890

12 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 21, 2018
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Auro Pharmacies, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

12 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 12

CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1156-2018
Recall number
D-1156-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
39 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180626/3, Exp 25-Aug-18

Distribution pattern

Nationwide in USA

drug · product 2 of 12

Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1157-2018
Recall number
D-1157-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
167 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180626/10, Exp 24-Sep-18

Distribution pattern

Nationwide in USA

drug · product 3 of 12

Dexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1158-2018
Recall number
D-1158-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
91 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180529/2, Exp 27-Aug-18 and 180620/11, Exp 18-Sep-18

Distribution pattern

Nationwide in USA

drug · product 4 of 12

Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1159-2018
Recall number
D-1159-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
183 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180716/21, Exp 14-Oct-18

Distribution pattern

Nationwide in USA

drug · product 5 of 12

Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1160-2018
Recall number
D-1160-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
114 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: a) 180618/2, Exp 16-Sep-18; b) 180618/2, Exp 16-Sep-18

Distribution pattern

Nationwide in USA

drug · product 6 of 12

Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1161-2018
Recall number
D-1161-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
90 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180618/3, Exp 16-Sep-18

Distribution pattern

Nationwide in USA

drug · product 7 of 12

Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1162-2018
Recall number
D-1162-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
81 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180702/1, Exp 30-Sep-18

Distribution pattern

Nationwide in USA

drug · product 8 of 12

Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1163-2018
Recall number
D-1163-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
43 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180709/21, Exp 07-Sep-18

Distribution pattern

Nationwide in USA

drug · product 9 of 12

Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 mL and 8 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1164-2018
Recall number
D-1164-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
32 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180606/18, Exp 30-Nov-18

Distribution pattern

Nationwide in USA

drug · product 10 of 12

Testosterone Enanthate/Cypionate injectable, 126/54 mg/mL, packaged in a) 3 mL and b) 5 mL Multiple Dose vials, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1165-2018
Recall number
D-1165-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
11 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180709/24, Exp 07-Sep-18

Distribution pattern

Nationwide in USA

drug · product 11 of 12

Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1166-2018
Recall number
D-1166-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
40 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180611/1, Exp 09-Sep-18

Distribution pattern

Nationwide in USA

drug · product 12 of 12

Methyl-Cobalamin injectable, 2 mg/mL, 30 ml Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520 W. La Habra Blvd, La Habra, CA 90631

D-1167-2018
Recall number
D-1167-2018
Initiated
August 21, 2018
Classification
Class II
Status
Terminated
Recalling firm
Auro Pharmacies, Inc.
Quantity
74 vials

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0
Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of products intended to be sterile.

Code information

Lot #: 180620/2, Exp 18-Sep-18

Distribution pattern

Nationwide in USA